You have 9 free searches left this month | for more free features.

City

Beijing (1)

Condition

Advanced Solid Tumor (1)

Gastric Cancer (1)

Gastroesophageal-junction Cancer (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Henan Cancer Hospital (1)

Innovent Biologics (Suzhou) Co. Ltd. (1)

Collaborator

Intervention

ibi315 (2)

anrotinib (1)

capecitabine (1)

oxaliplatin (1)

tqb2450 (1)

tst001 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

ibi315

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

Not yet recruiting

Gastric Cancer
Gastroesophageal-junction Cancer

IBI315
+5 more

(no location specified)

Nov 2, 2022

Advanced Solid Tumor Trial in Beijing (IBI315)

Recruiting

Advanced Solid Tumor

IBI315

Beijing, China

The 307th Hospital of Chinese People's Liberation Army

Nov 27, 2019